Why is Zydus Lifesci. falling/rising?

As of 23-Sep, Zydus Lifesciences Ltd's stock price is rising, currently at 1,045.40, reflecting an increase of 9.95 or 0.96%. The stock has shown a positive trend, gaining after two consecutive days of decline, and is currently trading 4.06% away from its 52-week high. It has outperformed its sector by 1.31% today and is trading above all key moving averages, indicating strong momentum. Over the past week, the stock has increased by 1.14%, and over the past month, it has risen by 5.60%, contrasting with the Sensex, which has seen a slight decline of 0.34% in the same period. Despite a recent drop in investor participation, with delivery volume falling by 18.14% against the 5-day average, the company's strong fundamentals, including a low debt-to-equity ratio and consistent profit growth, support its upward movement.
Broader Market Context: The broader market context shows that while the Sensex has gained 0.98% over the past month, Zydus Lifesciences Ltd has significantly outperformed this benchmark with a 5.60% increase. The company's strong financial health, evidenced by a healthy return on equity and consistent positive results over the last nine quarters, positions it favorably compared to its peers. Additionally, being rated among the top companies by MarketsMojo enhances investor confidence, contributing to the stock's upward trajectory despite the recent decline in trading volume. Overall, the combination of solid financial performance and favorable market positioning has led to the stock's rise.